PHACOEMULSIFICATION WITH INTRAVITREAL BEVACIZUMAB INJECTION IN DIABETIC PATIENTS WITH MACULAR EDEMA AND CATARACT

Abstract

Phacoemulsification with intravitreal injection of bevacizumab provides improvement in clinically significant macular edema with a gain in BCVA in patients with diabetes with clinically significant macular edema and cataract.